NUCLEAR MEDICINE: Discovery NM/CT 670 CZT

Bring Theory to Life with CZT

Introducing Discovery™ NM/CT 670 CZT, the first commercially-available general purpose SPECT/CT system powered by CZT technology. Help bring your theories to life with a system designed to leverage all that CZT can do.

Technology

The Future of Nuclear Medicine is Here

Engineered for improvements in lesion detection(1), image quality and patient comfort and combined with advanced quantitative applications provided through Xeleris™, this system renews the promise of nuclear medicine's potential for true discovery.

The Resolution to Discover Something New

  • Continue your efforts to diagnose and stage disease earlier with smaller lesion detectability(1)
  • Discover new protocols enabling differential diagnosis by visualizing multiple tracers simultaneously
  • More accurately assess treatment response to guide your treatment planning decisions with increased quantitation accuracy(2)
  • Enhance the patient experience by completing multiple exams in a single visit and single instances on the scanner bed
  • Increase patient satisfaction by reducing compromised exams, limiting repeat scans
  • Push nuclear medicine's boundaries by developing new diagnostic services
  • Grow patient volumes with referring physicians that value accurate, reproducible results and the diagnostic confidence you deliver
  • Pursue opportunities for tracer development and better utilization of currently available tracers

Designed to Make Every Inch Count

  • Improve imaging results by scanning in closer proximity to your patients
  • Provide more tolerable exams for greater patient comfort
  • Expand offerings that could provide economic and clinical benefits

Fast Facts

  • checkmark
    Greater than 40 percent improvement in SPECT contrast-to-noise ratio.3
  • preview-eyeball
    Improved system spatial resolution, from 4.3 to 2.8 mm.
  • pill
    Up to 75 percent reduction in injected dose or scan time.4
  • statistics
    Less than 4 minutes each for Bone SPECT and WB Bone exams.5
  • info
    Optimal FOV 25 percent greater than Nal, maintaining image quality towards smaller edges.
  • certificate
    Exceptional energy resolution of 6.3 percent, enabling exploration of new protocols with the variety of SPECT tracers available.

Supporting Materials

  • Discovery NM/CT 670 CZT - Bone Imaging

    Download
  • Discovery NM/CT 670 CZT Customer Spotlight: University Hospital Lyon

    Download
  • Discovery NM/CT 670 CZT Case Study: Barnes Jewish Hospital Upgrade

    Download
   
Contact Us

1. In clinical practice, the use of Discovery NM/CT 670 CZT may improve lesion detectability depending on the clinical task, patient size, anatomical location and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose or scan time to obtain diagnostic image quality for the particular clinical task.
2. In clinical practice, the use of Discovery NM/CT 670 CZT may improve quantitation of lesions larger than 5.5 mL, depending on the clinical task, patient size, anatomical location and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose or scan time to obtain the claimed quantitation accuracy for the particular clinical task.
3. Demonstrated in phantom testing using NEMA IEC Body Phantom at 50% scan times with Evolution. Compared to Discovery NM/CT 670 Pro/ES/DR.
4. Together with Clarity 2D and Evolution and compared to Discovery NM/CT 670 Pro/ES/DR without Clarity 2D and Evolution. As demonstrated in phantom testing using NEMA IEC Body Phantom.
5. Together with Clarity 2D and Evolution. Compared to typical 15 minute scan on Discovery NM/CT 670 Pro/ES/DR without Clarity 2D and Evolution.